단백질 칩 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년) - 제품별, 기술별, 등급별, 용도별, 최종사용자별, 지역별

The global protein chip market is experiencing rapid growth, driven by the increasing prevalence of chronic diseases and the demand for advanced treatment options. The evolution of the healthcare sector has been a major influencer for the market's growth, with a growing need for improved disease monitoring and clinical diagnostics. The protein microarray method, which allows for a wide range of analyses in a single experiment, has become a unique selling point, contributing to the market's expansion. Fairfield Market Research's preliminary findings indicate that the high prevalence of cancer worldwide is expected to underpin the growth of the protein chip market.

Protein Chip Market Benefitting from COVID-19 Outbreak and Cancer Prevalence

The outbreak of COVID-19 has highlighted the importance of diagnostics in containing the pandemic, leading to a surge in demand for functional analysis methods. This has made functional analysis a lucrative area of growth as researchers focus on identifying protein-virus interactions through various testing methods.

Cancer, on the other hand, remains a key cause of shortened life expectancy globally. According to the World Health Organization (WHO), there were over 19 million new cancer cases and approximately 10 million cancer-related deaths in 2020. The critical role of protein chips in efficient cancer diagnosis, allowing fast and easy diagnostics with parallel tracking of various protein interactions, targets, small molecules, substrates of protein kinases, and protein-phospholipid interactions, will drive market demand. The broad application scope of protein chips in molecular biology and biochemistry, along with the growing sector of personalized medicine, further enhances their significance in the healthcare industry.

Proteomics Emerges as the Leading Application for Protein Chips

As of 2019, proteomics stood as the leading application area for protein chips, and it is expected to maintain this position in the coming years. Its wide usage in biomedical research and drug discovery is anticipated to be a major revenue generator for the market. Proteomics is deployed in various techniques, including superficial fluid chromatography, chromatography, x-ray crystallography, protein fractionation, spectroscopy, surface plasmon resonance, and electrophoresis. Its ability to offer accurate analysis of in-vivo outcomes makes it an essential tool in the study of tumour resistance mechanisms, disease pathogenesis, and therapeutic developments.

North America and Europe to Lead the Global Protein Chip Market

North America is expected to maintain its dominance in the global protein chip market from 2021 to 2026. Well-established biotech companies in the region are projected to invest significantly in research and development of innovative technologies. Europe is also expected to show positive growth due to the rising incidence of cancer and COVID-19, prompting swift action. Analysts anticipate that Asia Pacific will closely follow this development, with protein chip adoption for diagnostics presenting lucrative opportunities in the region.

Key Players in the Global Protein Chip Market

The competitive landscape of the global protein chip market is shaped by leading players such as Sigma Aldrich Corporation, Affymetrix, Inc., Biacore, SEQUENOM, Inc., Illumina, Inc., Agilent Technologies, HTS Biosystems, EMD Millipore, Life Technologies Corporation, Lumicyte, and Ciphergen Biosystems.

Table of Contents

1. Executive Summary

• 1.1. Global Protein Chip Market Outlook, 2018 - 2030 (US$ Million)
• 1.2. Global Protein Chip Market Incremental Opportunity, 2018 - 2030 (US$ Million)
• 1.3. Key Industry Trends

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
    • 2.2.1.1. Driver 1
    • 2.2.1.2. Driver 2
  • 2.2.2. Restraints
    • 2.2.2.1. Restraint 1
    • 2.2.2.2. Restraint 2
  • 2.2.3. Market Opportunities Matrix
• 2.3. Porters Five Forces Analysis
• 2.4. Regulatory Guidelines & Reimbursement Scenario
• 2.5. Covid-19 Impact Analysis

3. Pricing Analysis, 2021

• 3.1. Average Selling Price, by Key Regions

4. Global Protein Chip Market Outlook, 2018 - 2030

• 4.1. Global Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  • 4.1.1. Key Highlights
    • 4.1.1.1. Functional
    • 4.1.1.2. Analytical
    • 4.1.1.3. Reverse Phase
    • 4.1.1.4. Others
  • 4.1.2. BPS Analysis/Market Attractiveness Analysis

5. Global Protein Chip Market Outlook, 2018 - 2030

• 5.1. Global Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  • 5.1.1. Key Highlights
    • 5.1.1.1. Diagnostics
    • 5.1.1.2. Proteomics
    • 5.1.1.3. Drug Discovery
    • 5.1.1.4. Biomarker Research
    • 5.1.1.5. Others
  • 5.1.2. BPS Analysis/Market Attractiveness Analysis
• 5.2. Global Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  • 5.2.1. Key Highlights
    • 5.2.1.1. Pharmaceutical & Biotech Companies
    • 5.2.1.2. Hospitals & Clinics
    • 5.2.1.3. Diagnostic Laboratories
    • 5.2.1.4. Research Institutes
    • 5.2.1.5. Others
  • 5.2.2. BPS Analysis/Market Attractiveness Analysis
• 5.3. Global Protein Chip Market Outlook, by Region, Value (US$ Mn), 2018 - 2030
  • 5.3.1. Key Highlights
    • 5.3.1.1. North America
    • 5.3.1.2. Europe
    • 5.3.1.3. Asia Pacific
    • 5.3.1.4. Rest of the World
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. North America Protein Chip Market Outlook, 2018 - 2030

• 6.1. North America Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  • 6.1.1. Key Highlights
    • 6.1.1.1. Functional
    • 6.1.1.2. Analytical
    • 6.1.1.3. Reverse Phase
    • 6.1.1.4. Others
  • 6.1.2. BPS Analysis/Market Attractiveness Analysis
• 6.2. North America Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  • 6.2.1. Key Highlights
    • 6.2.1.1. Diagnostics
    • 6.2.1.2. Proteomics
    • 6.2.1.3. Drug Discovery
    • 6.2.1.4. Biomarker Research
    • 6.2.1.5. Others
  • 6.2.2. BPS Analysis/Market Attractiveness Analysis
• 6.3. North America Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  • 6.3.1. Key Highlights
    • 6.3.1.1. Pharmaceutical & Biotech Companies
    • 6.3.1.2. Hospitals & Clinics
    • 6.3.1.3. Diagnostic Laboratories
    • 6.3.1.4. Research Institutes
    • 6.3.1.5. Others
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis
• 6.4. North America Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  • 6.4.1. Key Highlights
    • 6.4.1.1. U.S.
    • 6.4.1.2. Canada
  • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Protein Chip Market Outlook, 2018 - 2030

• 7.1. Europe Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  • 7.1.1. Key Highlights
    • 7.1.1.1. Functional
    • 7.1.1.2. Analytical
    • 7.1.1.3. Reverse Phase
    • 7.1.1.4. Others
  • 7.1.2. BPS Analysis/Market Attractiveness Analysis
• 7.2. Europe Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  • 7.2.1. Key Highlights
    • 7.2.1.1. Diagnostics
    • 7.2.1.2. Proteomics
    • 7.2.1.3. Drug Discovery
    • 7.2.1.4. Biomarker Research
    • 7.2.1.5. Others
  • 7.2.2. BPS Analysis/Market Attractiveness Analysis
• 7.3. Europe Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  • 7.3.1. Key Highlights
    • 7.3.1.1. Pharmaceutical & Biotech Companies
    • 7.3.1.2. Hospitals & Clinics
    • 7.3.1.3. Diagnostic Laboratories
    • 7.3.1.4. Research Institutes
    • 7.3.1.5. Others
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis
• 7.4. Europe Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  • 7.4.1. Key Highlights
    • 7.4.1.1. Germany
    • 7.4.1.2. France
    • 7.4.1.3. U.K.
    • 7.4.1.4. Italy
    • 7.4.1.5. Spain
    • 7.4.1.6. Rest of Europe
  • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Protein Chip Market Outlook, 2018 - 2030

• 8.1. Asia Pacific Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  • 8.1.1. Key Highlights
    • 8.1.1.1. Functional
    • 8.1.1.2. Analytical
    • 8.1.1.3. Reverse Phase
    • 8.1.1.4. Others
  • 8.1.2. BPS Analysis/Market Attractiveness Analysis
• 8.2. Asia Pacific Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  • 8.2.1. Key Highlights
    • 8.2.1.1. Diagnostics
    • 8.2.1.2. Proteomics
    • 8.2.1.3. Drug Discovery
    • 8.2.1.4. Biomarker Research
    • 8.2.1.5. Others
  • 8.2.2. BPS Analysis/Market Attractiveness Analysis
• 8.3. Asia Pacific Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  • 8.3.1. Key Highlights
    • 8.3.1.1. Pharmaceutical & Biotech Companies
    • 8.3.1.2. Hospitals & Clinics
    • 8.3.1.3. Diagnostic Laboratories
    • 8.3.1.4. Research Institutes
    • 8.3.1.5. Others
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis
• 8.4. Asia Pacific Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  • 8.4.1. Key Highlights
    • 8.4.1.1. China
    • 8.4.1.2. Japan
    • 8.4.1.3. India
    • 8.4.1.4. South Korea
    • 8.4.1.5. Australia & New Zealand
    • 8.4.1.6. Rest of Asia Pacific
  • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Rest of the World Protein Chip Market Outlook, 2018 - 2030

• 9.1. Rest of the World Protein Chip Market Outlook, by Technology, Value (US$ Mn), 2018 - 2030
  • 9.1.1. Key Highlights
    • 9.1.1.1. Functional
    • 9.1.1.2. Analytical
    • 9.1.1.3. Reverse Phase
    • 9.1.1.4. Others
  • 9.1.2. BPS Analysis/Market Attractiveness Analysis
• 9.2. Rest of the World Protein Chip Market Outlook, by Application, Value (US$ Mn), 2018 - 2030
  • 9.2.1. Key Highlights
    • 9.2.1.1. Diagnostics
    • 9.2.1.2. Proteomics
    • 9.2.1.3. Drug Discovery
    • 9.2.1.4. Biomarker Research
    • 9.2.1.5. Others
  • 9.2.2. BPS Analysis/Market Attractiveness Analysis
• 9.3. Rest of the World Protein Chip Market Outlook, by End User, Value (US$ Mn), 2018 - 2030
  • 9.3.1. Key Highlights
    • 9.3.1.1. Pharmaceutical & Biotech Companies
    • 9.3.1.2. Hospitals & Clinics
    • 9.3.1.3. Diagnostic Laboratories
    • 9.3.1.4. Research Institutes
    • 9.3.1.5. Others
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis
• 9.4. Rest of the World Protein Chip Market Outlook, by Country, Value (US$ Mn), 2018 - 2030
  • 9.4.1. Key Highlights
    • 9.4.1.1. Latin America
    • 9.4.1.2. Middle East & Africa
  • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

• 10.1. Company Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1. ArrayIt Corporation
    • 10.2.1.1. Company Overview
    • 10.2.1.2. Financial Overview
    • 10.2.1.3. Technology Portfolio
    • 10.2.1.4. Recent Developments
  • 10.2.2. PerkinElmer, Inc.
  • 10.2.3. Thermo Fischer Scientific
  • 10.2.4. Lumicyte
  • 10.2.5. Bio-Rad Laboratories
  • 10.2.6. Illumina, Inc.
  • 10.2.7. Ciphergen Biosystems
  • 10.2.8. Agilent Technologies
  • 10.2.9. Others

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations